cbdMD (YCBD) EBIT: 2016-2025
Historic EBIT for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -$685,816.
- cbdMD's EBIT fell 116.65% to -$685,816 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 34.77%. This contributed to the annual value of -$2.2 million for FY2025, which is 34.77% up from last year.
- cbdMD's EBIT amounted to -$685,816 in Q3 2025, which was up 24.19% from -$904,686 recorded in Q2 2025.
- cbdMD's EBIT's 5-year high stood at -$86,272 during Q4 2024, with a 5-year trough of -$33.1 million in Q2 2022.
- In the last 3 years, cbdMD's EBIT had a median value of -$904,686 in 2025 and averaged -$2.2 million.
- Its EBIT has fluctuated over the past 5 years, first tumbled by 1,328.74% in 2021, then soared by 97.92% in 2024.
- cbdMD's EBIT (Quarterly) stood at -$25.1 million in 2021, then surged by 83.91% to -$4.0 million in 2022, then spiked by 73.66% to -$1.1 million in 2023, then soared by 91.91% to -$86,272 in 2024, then plummeted by 116.65% to -$685,816 in 2025.
- Its EBIT stands at -$685,816 for Q3 2025, versus -$904,686 for Q2 2025 and -$485,816 for Q1 2025.